Research progress of cerebral blood flow measured by arterial spin labeling in Alzheimer's disease

doi:10.3969/j.issn.1672-6731.2023.01.006

Abstract

Abstract: Cerebral blood flow (CBF) changes are closely related to Alzheimer's disease (AD). Arterial spin labeling (ASL) uses water proton in blood as an endogenous contrast agent to obtain CBF, which has attracted must attention in AD studies due to its advantages of non-invasiveness and safety. However, there is still a lack of uniformity in the implementation of ASL in clinical settings, and limited by sample size and different population cohorts, research results may be different or lack of universality, which lead to the fact that this technology has not yet been widely applied in AD. This article reviews the new research progress on the correlation between CBF measured by ASL and AD disease process, pathologic biomarkers, vascular pathological burden, apolipoprotein E ε4 (ApoEε4) gene, and cognitive impairment development, in order to provide guidance for the clinical application of ASL in AD.

Key words: Alzheimer disease, Cerebrovascular circulation, Magnetic resonance imaging, Biomarkers, Review

摘要： 脑血流量变化与阿尔茨海默病进程密切相关。动脉自旋标记（ASL）以血液中水质子作为内源性对比剂获得脑血流量，以其无创性、安全等优点在阿尔茨海默病研究中备受关注，但在各项研究中的实施方案尚缺乏一致性，且受样本量和人群队列选择的限制，研究结论不尽一致，导致其在阿尔茨海默病研究中的应用较为局限。本文综述ASL测定脑血流量与阿尔茨海默病病程、病理学标志物、血管病理负担、载脂蛋白Eε4（ApoEε4）等位基因及认知功能障碍进展之间的研究进展，为推动ASL在阿尔茨海默病研究中的应用提供指导。

关键词: 阿尔茨海默病, 脑血管循环, 磁共振成像, 生物标记, 综述

SUN Meng-fan, JIANG Ji-wei, WANG Yan-li, ZHANG Yuan, XU Jun. Research progress of cerebral blood flow measured by arterial spin labeling in Alzheimer's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2023, 23(1): 29-34.

孙梦凡, 姜季委, 王艳丽, 张源, 徐俊. 动脉自旋标记测定脑血流量在阿尔茨海默病研究中的进展[J]. 中国现代神经疾病杂志, 2023, 23(1): 29-34.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2023.01.006

https://journal11.magtechjournal.com/cjcnn/EN/Y2023/V23/I1/29

References

[1] Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT. Alzheimer disease[J]. Nat Rev Dis Primers, 2021, 7:33.
[2] Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders[J]. Nat Rev Neurosci, 2011, 12:723-738.
[3] Narayanan S, Schmithorst V, Panigrahy A. Arterial spin labeling in pediatric neuroimaging[J]. Semin Pediatr Neurol, 2020, 33:100799.
[4] Bambach S, Smith M, Morris PP, Campeau NG, Ho ML. Arterial spin labeling applications in pediatric and adult neurologic disorders[J]. J Magn Reson Imaging, 2022, 55:698-719.
[5] Quality Management and Safety Management Group, Radiology Branch, Chinese Medical Association; Magnetic Resonance Group, Radiology Branch, Chinese Medical Association. Expert consensus on standardized application of arterial spin labeled brain perfusion MRI[J]. Zhonghua Fang She Xue Za Zhi, 2016, 50:817-824. 中华医学会放射学分会质量管理与安全管理学组, 中华医学会放射学分会磁共振学组. 动脉自旋标记脑灌注MRI技术规范化应用专家共识[J]. 中华放射学杂志, 2016, 50:817-824.
[6] Golay X, Ho ML. Multidelay ASL of the pediatric brain[J]. Br J Radiol, 2022, 95:20220034.
[7] Huang CW, Hsu SW, Chang YT, Huang SH, Huang YC, Lee CC, Chang WN, Lui CC, Chen NC, Chang CC. Cerebral perfusion insufficiency and relationships with cognitive deficits in Alzheimer's disease:a multiparametric neuroimaging study[J]. Sci Rep, 2018, 8:1541.
[8] Suo X, Lei D, Cheng L, Li N, Zuo P, Wang DJJ, Huang X, Lui S, Kemp GJ, Peng R, Gong Q. Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease[J]. Hum Brain Mapp, 2019, 40:1317-1327.
[9] Sun M, Wang YL, Li R, Jiang J, Zhang Y, Li W, Zhang Y, Jia Z, Chappell M, Xu J. Potential diagnostic applications of multi-delay arterial spin labeling in early Alzheimer's disease:the Chinese imaging, biomarkers, and lifestyle study[J]. Front Neurosci, 2022, 16:934471.
[10] Dai W, Fong T, Jones RN, Marcantonio E, Schmitt E, Inouye SK, Alsop DC. Effects of arterial transit delay on cerebral blood flow quantification using arterial spin labeling in an elderly cohort[J]. J Magn Reson Imaging, 2017, 45:472-481.
[11] Xu X, Tan Z, Fan M, Ma M, Fang W, Liang J, Xiao Z, Shi C, Luo L. Comparative study of multi-delay pseudo-continuous arterial spin labeling perfusion MRI and CT perfusion in ischemic stroke disease[J]. Front Neuroinform, 2021, 15:719719.
[12] Chappell MA, McConnell FAK, Golay X, Günther M, Hernandez-Tamames JA, van Osch MJ, Asllani I. Partial volume correction in arterial spin labeling perfusion MRI:a method to disentangle anatomy from physiology or an analysis step too far[J]? Neuroimage, 2021, 238:118236.
[13] Ahlgren A, Wirestam R, Petersen ET, Ståhlberg F, Knutsson L. Partial volume correction of brain perfusion estimates using the inherent signal data of time-resolved arterial spin labeling[J]. NMR Biomed, 2014, 27:1112-1122.
[14] Ssali T, Anazodo UC, Narciso L, Liu L, Jesso S, Richardson L, Günther M, Konstandin S, Eickel K, Prato F, Finger E, St Lawrence K. Sensitivity of arterial spin labeling for characterization of longitudinal perfusion changes in frontotemporal dementia and related disorders[J]. Neuroimage Clin, 2022, 35:102853.
[15] Claassen JA, Jansen RW. Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders:the cholinergic-vascular hypothesis[J]. J Gerontol A Biol Sci Med Sci, 2006, 61:267-271.
[16] Althubeati S, Avery A, Tench CR, Lobo DN, Salter A, Eldeghaidy S. Mapping brain activity of gut-brain signaling to appetite and satiety in healthy adults:a systematic review and functional neuroimaging meta-analysis[J]. Neurosci Biobehav Rev, 2022, 136:104603.
[17] Charroud C, Menjot de Champfleur N, Sanrey E, Pfeuffer J, Deverdun J, Le Bars E, Coubes P. Differential effects of hunger on cerebral blood flow in healthy adolescents[J]. Behav Brain Res, 2020, 383:112505.
[18] Hays CC, Zlatar ZZ, Wierenga CE. The utility of cerebral blood flow as a biomarker of preclinical Alzheimer's disease[J]. Cell Mol Neurobiol, 2016, 36:167-179.
[19] Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, Rabin L, Rentz DM, Rodriguez-Gomez O, Saykin AJ, Sikkes SAM, Smart CM, Wolfsgruber S, Wagner M. The characterisation of subjective cognitive decline[J]. Lancet Neurol, 2020, 19:271-278.
[20] Li W, Jiang J, Zou X, Zhang Y, Sun M, Jia Z, Li W, Xu J. The characteristics of arterial spin labeling cerebral blood flow in patients with subjective cognitive decline:the Chinese imaging, biomarkers, and lifestyle study[J]. Front Neurosci, 2022, 16:961164.
[21] Duan W, Sehrawat P, Balachandrasekaran A, Bhumkar AB, Boraste PB, Becker JT, Kuller LH, Lopez OL, Gach HM, Dai W. Cerebral blood flow is associated with diagnostic class and cognitive decline in Alzheimer's disease[J]. J Alzheimers Dis, 2020, 76:1103-1120.
[22] Sierra-Marcos A. Regional cerebral blood flow in mild cognitive impairment and Alzheimer's disease measured with arterial spin labeling magnetic resonance imaging[J]. Int J Alzheimers Dis, 2017:ID5479597.
[23] Ma HR, Pan PL, Sheng LQ, Dai ZY, Wang GD, Luo R, Chen JH, Xiao PR, Zhong JG, Shi HC. Aberrant pattern of regional cerebral blood flow in Alzheimer's disease:a voxel-wise meta-analysis of arterial spin labeling MR imaging studies[J]. Oncotarget, 2017, 8:93196-93208.
[24] Juttukonda MR, Li B, Almaktoum R, Stephens KA, Yochim KM, Yacoub E, Buckner RL, Salat DH. Characterizing cerebral hemodynamics across the adult lifespan with arterial spin labeling MRI data from the Human Connectome Project-Aging[J]. Neuroimage, 2021, 230:117807.
[25] Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer's disease[J]. Acta Neuropathol, 2016, 131:645-658.
[26] Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Møller A, Brændgaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ. The capillary dysfunction hypothesis of Alzheimer's disease[J]. Neurobiol Aging, 2013, 34:1018-1031.
[27] Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease[J]. J Magn Reson Imaging, 2020, 51:505-513.
[28] Bangen KJ, Clark AL, Edmonds EC, Evangelista ND, Werhane ML, Thomas KR, Locano LE, Tran M, Zlatar ZZ, Nation DA, Bondi MW, Delano-Wood L. Cerebral blood flow and amyloid-β interact to affect memory performance in cognitively normal older adults[J]. Front Aging Neurosci, 2017, 9:181.
[29] Yan L, Liu CY, Wong KP, Huang SC, Mack WJ, Jann K, Coppola G, Ringman JM, Wang DJJ. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease[J]. Neuroimage Clin, 2017, 17:751-760.
[30] Rubinski A, Tosun D, Franzmeier N, Neitzel J, Frontzkowski L, Weiner M, Ewers M. Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum[J]. Neurobiol Aging, 2021, 102:111-118.
[31] Gauthier S, Zhang H, Ng KP, Pascoal TA, Rosa-Neto P. Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN):what about the role of vascular changes, inflammation, Lewy body pathology[J]? Transl Neurodegener, 2018, 7:12.
[32] Bagi Z, Kroenke CD, Fopiano KA, Tian Y, Filosa JA, Sherman LS, Larson EB, Keene CD, Degener O'Brien K, Adeniyi PA, Back SA. Association of cerebral microvascular dysfunction and white matter injury in Alzheimer's disease[J]. Geroscience, 2022, 44:1-14.
[33] Badji A, Westman E. Cerebrovascular pathology in Alzheimer's disease:hopes and gaps[J]. Psychiatry Res Neuroimaging, 2020, 306:111184.
[34] Neumann K, Günther M, Düzel E, Schreiber S. Microvascular impairment in patients with cerebral small vessel disease assessed with arterial spin labeling magnetic resonance imaging:a pilot study[J]. Front Aging Neurosci, 2022, 14:871612.
[35] Zhang R, Huang P, Wang S, Jiaerken Y, Hong H, Zhang Y, Yu X, Lou M, Zhang M. Decreased cerebral blood flow and delayed arterial transit are independently associated with white matter hyperintensity[J]. Front Aging Neurosci, 2022, 14:762745.
[36] Ferro DA, Mutsaerts HJ, Hilal S, Kuijf HJ, Petersen ET, Petr J, van Veluw SJ, Venketasubramanian N, Yeow TB, Biessels GJ, Chen C. Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion[J]. J Cereb Blood Flow Metab, 2020, 40:1869-1878.
[37] Huang H, Zhao K, Zhu W, Li H, Zhu W. Abnormal cerebral blood flow and functional connectivity strength in subjects with white matter hyperintensities[J]. Front Neurol, 2021, 12:752762.
[38] Promjunyakul NO, Dodge HH, Lahna D, Boespflug EL, Kaye JA, Rooney WD, Silbert LC. Baseline NAWM structural integrity and CBF predict periventricular WMH expansion over time[J]. Neurology, 2018, 90:e2119-2126.
[39] McKiernan EF, Mak E, Dounavi ME, Wells K, Ritchie C, Williams G, Su L, O'Brien J. Regional hyperperfusion in cognitively normal APOE ε4 allele carriers in mid-life:analysis of ASL pilot data from the PREVENT-Dementia cohort[J]. J Neurol Neurosurg Psychiatry, 2020, 91:861-866.
[40] Michels L, Warnock G, Buck A, Macauda G, Leh SE, Kaelin AM, Riese F, Meyer R, O'Gorman R, Hock C, Kollias S, Gietl AF. Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers[J]. J Cereb Blood Flow Metab, 2016, 36:581-595.
[41] Wang J, Peng G, Liu P, Tan X, Luo B; Alzheimer's Disease Neuroimaging Initiative. Regulating effect of CBF on memory in cognitively normal older adults with different ApoE genotype:the Alzheimer's Disease Neuroimaging Initiative (ADNI)[J]. Cogn Neurodyn, 2019, 13:513-518.
[42] Benedictus MR, Leeuwis AE, Binnewijzend MA, Kuijer JP, Scheltens P, Barkhof F, van der Flier WM, Prins ND. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease[J]. Eur Radiol, 2017, 27:1169-1175.
[43] Bangen KJ, Thomas KR, Sanchez DL, Edmonds EC, Weigand AJ, Delano-Wood L, Bondi MW; Alzheimer's Disease Neuroimaging Initiative. Entorhinal perfusion predicts future memory decline, neurodegeneration, and white matter hyperintensity progression in older adults[J]. J Alzheimers Dis, 2021, 81:1711-1725.
[44] De Vis JB, Peng SL, Chen X, Li Y, Liu P, Sur S, Rodrigue KM, Park DC, Lu H. Arterial-spin-labeling (ASL) perfusion MRI predicts cognitive function in elderly individuals:a 4-year longitudinal study[J]. J Magn Reson Imaging, 2018, 48:449-458.
[45] Duan W, Zhou GD, Balachandrasekaran A, Bhumkar AB, Boraste PB, Becker JT, Kuller LH, Lopez OL, Gach HM, Dai W. Cerebral blood flow predicts conversion of mild cognitive impairment into Alzheimer's disease and cognitive decline:an arterial spin labeling follow-up study[J]. J Alzheimers Dis, 2021, 82:293-305.
[46] Weijs RWJ, Shkredova DA, Brekelmans ACM, Thijssen DHJ, Claassen JAHR. Longitudinal changes in cerebral blood flow and their relation with cognitive decline in patients with dementia:current knowledge and future directions[J]. Alzheimers Dement, 2022.[Epub ahead of print]

Please choose a citation manager

Content to export